The Renin-Angiotensin System in the Breast

  • Gavin P. Vinson
  • Stewart Barker
  • John R. Puddefoot
  • Massoumeh Tahmasebi

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ali, M.S., Sayeski, P.P., Bernstein, K.E., 2000, Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor. J Biol Chem 275, 15586–15593.PubMedGoogle Scholar
  2. Ambili, M., Jayasree, K., Sudhakaran, P.R., 1998, 60K gelatinase involved in mammary gland involution is regulated by beta-oestradiol. Biochim Biophys Acta 1403, 219–231.PubMedGoogle Scholar
  3. Anderson, J.H., Willmott, N., Bessent, R., Angerson, W.J., Kerr, D.J., McArdle, C.S., 1991, Regional chemotherapy for inoperable renal carcinoma: a method of targeting therapeutic microspheres to tumour. Br.J.Cancer. 64, 365–368.PubMedGoogle Scholar
  4. Bader, M., 2002, Role of the local Renin-Angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. J Mol Cell Cardiol 34, 1455–1462.PubMedGoogle Scholar
  5. Barcellos-Hoff, M.H., Medina, D., 2005, New highlights on stroma-epithelial interactions in breast cancer. Breast Cancer Res 7, 33–36.PubMedGoogle Scholar
  6. Barnes, D.M., Millis, R.R., Gillett, C.E., Ryder, K., Skilton, D., Fentiman, I.S., Rubens, R.D., 2004, The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients. Endocrine-Related Cancer 11, 85–96.PubMedGoogle Scholar
  7. Bedecs, K., Elbaz, N., Sutren, M., Masson, M., Susini, C., Strosberg, A.D., Nahmias, C., 1997, Angiotensin II type 2 receptors mediate inhibition of mitogen- activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem.J. 325, 449–454.PubMedGoogle Scholar
  8. Berry, C., Touyz, R., Dominiczak, A.F., Webb, R.C., Johns, D.G., 2001, Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol 281, H2337–H2365.Google Scholar
  9. Bianco, R., Daniele, G., Ciardiello, F., Tortora, G., 2005, Monoclonal antibodies targeting the epidermal growth factor receptor. Current Drug Targets 6, 275–287.PubMedGoogle Scholar
  10. Booz, G.W., Baker, K.M., 1995, Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 30, 537–543.PubMedGoogle Scholar
  11. Boutinaud, M., Guinard-Flament, J., Jammes, H., 2004, The number and activity of mammary epithelial cells, determining factors for milk production. Reprod Nutr Develop 44, 499–508.Google Scholar
  12. Chai, S.Y., Fernando, R., Peck, G., Ye, S.Y., Mendelsohn, F.A., Jenkins, T.A., Albiston, A.L., 2004, The angiotensin IV/AT4 receptor. Cell Mol Life Sci 61, 2728–2737.PubMedGoogle Scholar
  13. Chapman, A.B., Zamudio, S., Woodmansee, W., Merouani, A., Osorio, F., Johnson, A., Moore, L.G., Dahms, T., Coffin, C., Abraham, W.T., Schrier, R.W., 1997, Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol 42, F777–F782.Google Scholar
  14. Chen, L., Re, R.N., Prakash, O., Mondal, D., 1991, Angiotensin-converting enzyme-inhibition reduces neuroblastoma cell- growth rate. Proc Soc Exp Biol Med 196, 280–283.PubMedGoogle Scholar
  15. Chidambaram, M., Duncan, J.A., Lai, V.S., Cattran, D.C., Floras, J.S., Scholey, J.W., Miller, J.A., 2002, Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol 13, 446–452.PubMedGoogle Scholar
  16. Chiu, T., Santiskulvong, C., Rozengurt, E., 2005, EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway. Am J Physiol 288, G182–194.Google Scholar
  17. Chrenek, M.A., Wong, P., Weaver, V.M., 2001, Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast.Cancer Res. 3, 224–229.PubMedGoogle Scholar
  18. Clauser, E., Curnow, K.M., Davies, E., Conchon, S., Teutsch, B., Vianello, B., Monnot, C., Corvol, P., 1996, Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. Eur J Endocrinol 134, 403–411.PubMedGoogle Scholar
  19. D’Amore, A., Black, M.J., Thomas, W.G., 2005, The Angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor - Mediated hypertrophy. Hypertension 46, 1347–1354.PubMedGoogle Scholar
  20. de Gasparo, M., Catt, K.J., Inagami, T., Wright, J.W., Unger, T., 2000, International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52, 415–472.PubMedGoogle Scholar
  21. de Gasparo, M., 2002, AT(1) and AT(2) angiotensin II receptors: Key features. Drugs 62, 1–10.PubMedGoogle Scholar
  22. De Paepe, B., Verstraeten, V.L., De Potter, C.R., Vakaet, L.A., Bullock, G.R., 2001, Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma. Histochem.Cell Biol. 116, 247–254.PubMedGoogle Scholar
  23. De Paolis, P., Porcellini, A., Savoia, C., Lombardi, A., Gigante, B., Frati, G., Rubattu, S., Musumeci, B., Volpe, M., 2002, Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts. J Hypertens 20, 693–699.PubMedGoogle Scholar
  24. Dean, S.A., Tan, J., White, R., O’Brien E, R., Leenen, F.H., 2006, Regulation of components of the brain and cardiac renin-angiotensin systems by 17β-estradiol following myocardial infarction in female rats. Am J Physiol 291,R155–62Google Scholar
  25. Deshayes, F., Nahmias, C., 2005, Angiotensin receptors: a new role in cancer? Trends in Endocy Metab 16, 293–299.Google Scholar
  26. Dickson, R.B., Johnson, M.D., Bano, M., Shi, E., Kurebayashi, J., Ziff, B., Martinezlacaci, I., Amundadottir, L.T., Lippman, M.E., 1992, Growth-Factors in Breast-Cancer - Mitogenesis to Transformation. J steroid Biochem Mol Biol 43, 69–78.PubMedGoogle Scholar
  27. Diep, Q.N., El Mabrouk, M., Yue, P., Schiffrin, E.L., 2002, Effect of AT(1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension. Am J Physiol 282, H1635–H1641.Google Scholar
  28. Dinh, D.T., Frauman, A.G., Johnston, C.I., Fabiani, M.E., 2001, Angiotensin receptors: distribution, signalling and function. Clin.Sci.(Lond). 100, 481–492.CrossRefGoogle Scholar
  29. Dinh, D.T., Frauman, A.G., Somers, G.R., Ohishi, M., Zhou, J., Casley, D.J., Johnston, C.I., Fabiani, M.E., 2002, Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia. J.Pathol. 196, 213–229.PubMedGoogle Scholar
  30. Doan, T.N., Ali, M.S., Bernstein, K.E., 2001, Tyrosine kinase activation by the angiotensin II receptor in the absence of calcium signaling. J Biol Chem 276, 20954–20958.PubMedGoogle Scholar
  31. Duffy, M.J., Maguire, T.M., Hill, A., McDermott, E., O’Higgins, N., 2000, Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2, 252–257.PubMedGoogle Scholar
  32. Dzau, V.J., 2001, Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37, 1047–1052.PubMedGoogle Scholar
  33. Fischer, M., Baessler, A., Schunkert, H., 2002, Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53, 672–677.PubMedGoogle Scholar
  34. Ford, C.M., Li, S., Pickering, J.G., 1999, Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arterioscler Thromb Vasc Biol 19, 1843–1851.PubMedGoogle Scholar
  35. Fryzek, J.P., Poulsen, A.H., Lipworth, L., Pedersen, L., Norgaard, M., McLaughlin, J.K., Friis, S., 2006, A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treatment 97, 231–236.Google Scholar
  36. Fujimoto, Y., Sasaki, T., Tsuchida, A., Chayama, K., 2001, Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. Febs Letters 495, 197–200.PubMedGoogle Scholar
  37. Fujita, M., Hayashi, I., Yamashina, S., Itoman, M., Majima, M., 2002, Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem. Biophys. Res. Commun. 294, 441–447.PubMedGoogle Scholar
  38. Fujita, M., Hayashi, I., Yamashina, S., Fukamizu, A., Itoman, M., Majima, M., 2005, Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 26, 271–279.PubMedGoogle Scholar
  39. Gack, S., Vallon, R., Schaper, J., Ruther, U., Angel, P., 1994, Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein. J Biol Chem 269, 10363–10369.PubMedGoogle Scholar
  40. Galis, Z.S., Khatri, J.J., 2002, Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90, 251–262.PubMedGoogle Scholar
  41. Ganong, W.F., 1995, Reproduction and the renin-angiotensin system. Neurosci Biobehav Rev 19, 241–250.PubMedGoogle Scholar
  42. Goffin, V., Binart, N., Touraine, P., Kelly, P.A., 2002, Prolactin: The new biology of an old hormone. Ann Rev Physiol 64, 47–67.Google Scholar
  43. Goldberg, J.A., Kerr, D.J., Wilmott, N., McKillop, J.H., McArdle, C.S., 1990, Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br.J.Surg. 77, 1238–1240.PubMedGoogle Scholar
  44. Gonzalez-Perez, A., Ronquist, G., Rodriguez, L.A.G., 2004, Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidem Drug Safety 13, 581–585.Google Scholar
  45. Gordon, M.S., Chin, W.W., Shupnik, M.A., 1992, Regulation of Angiotensinogen Gene-Expression by Estrogen. J Hypertens 10, 361–366.PubMedGoogle Scholar
  46. Greco, S., Elia, M.G., Muscella, A., Storelli, C., Marsigliante, S., 2002a, AT1 angiotensin II receptor mediates intracellular calcium mobilization in normal and cancerous breast cells in primary culture. Cell Calcium 32, 1–10.Google Scholar
  47. Greco, S., Muscella, A., Elia, M.G., Salvatore, P., Storelli, C., Marsigliante, S., 2002b, Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells. J. Endocrinol. 174, 205–214.Google Scholar
  48. Greco, S., Muscella, A., Elia, M.G., Salvatore, P., Storelli, C., Mazzotta, A., Manca, C., Marsigliante, S., 2003, Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J. Cell. Physiol. 196, 370–377.PubMedGoogle Scholar
  49. Green, K.A., Streuli, C.H., 2004, Apoptosis regulation in the mammary gland. Cell Mol Life Sci 61, 1867–1883.PubMedGoogle Scholar
  50. Griendling, K.K., UshioFukai, M., Lassegue, B., Alexander, R.W., 1997, Angiotensin II signaling in vascular smooth muscle - new concepts. Hypertension 29, 366–373.PubMedGoogle Scholar
  51. Griendling, K.K., Sorescu, D., Ushio-Fukai, M., 2000, NAD(P)H oxidase - role in cardiovascular biology and disease. Circulation res 86, 494–501.PubMedGoogle Scholar
  52. Gross, V., Obst, M., Luft, F.C., 2004, Insights into angiotensin II receptor function through AT2 receptor knockout mice. Acta Physiol Scand 181, 487–494.PubMedGoogle Scholar
  53. Gupta, P., Francosaenz, R., Mulrow, P.J., 1995, Locally generated angiotensin-II in the adrenal-gland regulates basal, corticotropin-stimulated, and potassium-stimulated aldosterone secretion. Hypertension 25, 443–448.PubMedGoogle Scholar
  54. Haagensen, C., 1986, Diseases of the breast. Saunders, Philadelphia.Google Scholar
  55. Hagemann, A., Nielsen, A.H., Poulsen, K., 1994, The uteroplacental renin-angiotensin system - a review. Exp clin endocr 102, 252–261.CrossRefGoogle Scholar
  56. Hall, K.L., Venkateswaran, S., Hanesworth, J.M., Schelling, M.E., Harding, J.W., 1995, Characterization of a functional angiotensin-IV receptor on coronary microvascular endothelial-cells. Reg Peptides 58, 107–115.Google Scholar
  57. Hansen, R.K., Bissell, M.J., 2000, Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocrine-Related Cancer 7, 95–113.PubMedGoogle Scholar
  58. Haulica, I., Bild, W., Serban, D.N., 2005, Angiotensin peptides and their pleiotropic actions. J Renin Angiotensin Aldosterone Syst 6, 121–131.PubMedGoogle Scholar
  59. Horiuchi, M., Hayashida, W., Kambe, T., Yamada, T., Dzau, V.J., 1997, Angiotensin type 2 receptor dephosphorylates bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 272, 19022–19026.PubMedGoogle Scholar
  60. Horiuchi, M., Hamai, M., Cui, T.X., Iwai, H., Minokoshi, Y., 1999a, Cross talk between angiotensin II type 1 and type 2 receptors: Cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition. Hypertension Res Clin Exp 22, 67–74.Google Scholar
  61. Horiuchi, M., Lehtonen, J.Y.A., Daviet, L., 1999b, Signaling mechanism of the AT2 angiotensin II receptor: Crosstalk between AT1 and AT2 receptors in cell growth. Trends in Endocrinology and Metabolism 10, 391–396.Google Scholar
  62. Howell, A., Dowsett, M., 2004, Endocrinology and hormone therapy in breast cancer - Aromatase inhibitors versus antioestrogens. Breast Cancer Res 6, 269–274.PubMedGoogle Scholar
  63. Hunyady, L., Catt, K.J., 2006, Pleiotropic AT(1) receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocr 20, 953–970.Google Scholar
  64. Hynes, N.E., Lane, H.A., 2005, ERBB receptors and cancer: The complexity of targeted inhibitors. Nature Rev Cancer 5, 341–354.Google Scholar
  65. Inwang, E.R., Puddefoot, J.R., Brown, C.L., Goode, A.W., Marsigliante, S., Ho, M.M., Payne, J.G., Vinson, G.P., 1997, Angiotensin II type 1 receptor expression in human breast tissues. Br.J.Cancer 75, 1279–1283.PubMedGoogle Scholar
  66. Jarvis, M.F., Gessner, G.W., Ly, C.Q., 1992, The angiotensin hexapeptide 3–8 fragment potently inhibits [125I]angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortex. Eur J Pharm 219, 319–322.Google Scholar
  67. Johnston, C.I., 1992, Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J.Hypertens.Suppl. 10, S13–S26.PubMedGoogle Scholar
  68. Jones, K.L., Buzdar, A.U., 2004, A review of adjuvant hormonal therapy in breast cancer. Endocrine-Related Cancer 11, 391–406.PubMedGoogle Scholar
  69. Karakiulakis, G., Papakonstantinou, E., Aletras, A.J., Tamm, M., Roth, M., 2006, Cell type specific effect of hypoxia and PDGF-BB on extracellular matrix turnover and its consequences for lung remodelling. J Biol Chem Google Scholar
  70. Kaschina, E., Unger, T., 2003, Angiotensin AT1/AT2 receptors: Regulation, signalling and function. Blood Press 12, 70–88.PubMedGoogle Scholar
  71. Kisley, L.R., Sakai, R.R., Fluharty, S.J., 1999, Estrogen decreases hypothalamic angiotensin II AT(1) receptor binding and mRNA in the female rat. Brain Res 844, 34–42.PubMedGoogle Scholar
  72. Klett, C., Hellmann, W., Hackenthal, E., Ganten, D., 1993, Modulation of tissue angiotensinogen gene expression by glucocorticoids, estrogens, and androgens in SHR and WKY rats. Clin.Exp.Hypertens. 15, 683–708.PubMedGoogle Scholar
  73. Koh, W.P., Yuan, J.M., Van Den Berg, D., Lee, H.P., Yu, M.C., 2005, Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 26, 459–464.PubMedGoogle Scholar
  74. Kucerova, D., Zelezna, B., Sloncova, E., Sovova, V., 1998, Angiotensin II receptors on colorectal carcinoma cells. Int J Mol Med 2, 593–595.PubMedGoogle Scholar
  75. Lamote, I., Meyer, E., Massart-Leen, A.M., Burvenich, C., 2004, Sex steroids and growth factors in the regulation of mammary gland proliferation, differentiation, and involution. Steroids 69, 145–159.PubMedGoogle Scholar
  76. Lees, K.R., MacFadyen, R.J., Doig, J.K., Reid, J.L., 1993, Role of angiotensin in the extravascular system. J.Hum.Hypertens. 7, S 7-S 12.Google Scholar
  77. Leung, P.S., Chan, H.C., Fu, L.X., Zhou, W.L., Wong, P.Y., 1997, Angiotensin II receptors, AT1 and AT2 in the rat epididymis. Immunocytochemical and electrophysiological studies. Biochim.Biophys.Acta 1357, 65–72.PubMedGoogle Scholar
  78. Leung, P.S., Carlsson, P.O., 2001, Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas. J. Mol. Endocrinol. 26, 155–164.PubMedGoogle Scholar
  79. Leung, P.S., Carlsson, P.O., 2005, Pancreatic islet renin angiotensin system - Its novel roles in islet function and in diabetes mellitus. Pancreas 30, 293–298.PubMedGoogle Scholar
  80. Lever, A.F., Hole, D.J., Gillis, C.R., McCallum, I.R., McInnes, G.T., MacKinnon, P.L., Meredith, P.A., Murray, L.S., Reid, J.L., Robertson, J.W.K., 1998, Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352, 179–184.PubMedGoogle Scholar
  81. Li, C.I., Malone, K.E., Weiss, N.S., Boudreau, D.M., Cushing-Haugen, K.L., Daling, J.R., 2003a, Relation between use of anti hypertensive medications and risk of breast carcinoma among women ages 65–79 years. Cancer 98, 1504–1513.Google Scholar
  82. Li, X.P., Rayford, H., Uhal, B.D., 2003b, Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am J Path 163, 2523–2530.Google Scholar
  83. Li, Y.H., Jiao, L.H., Liu, R.H., Chen, X.L., Wang, H., Wang, W.H., 2004, Localization of angiotensin II in pig ovary and its effects on oocyte maturation in vitro. Theriogenology 61, 447–459.PubMedGoogle Scholar
  84. Lim, K.T., Cosgrave, N., Hill, A.D., Young, L.S., 2006, Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1. Breast Cancer Res 8,Google Scholar
  85. Lin, J.Q., Freeman, M.R., 2003, Transactivation of ErbBl and ErbB2 receptors by angiotensin II in normal human prostate stromal cells. Prostate 54, 1–7.PubMedGoogle Scholar
  86. Linz, W., Scholkens, B.A., Ganten, D., 1989, Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin.Exp.Hypertens.A. 11, 1325–1350.PubMedGoogle Scholar
  87. Magness, R.R., Parker, C.R., Rosenfeld, C.R., 1993, Systemic and Uterine Responses to Chronic Infusion of Estradiol-17-Beta. Am J Physiol 265, E690–E698.PubMedGoogle Scholar
  88. Magy, L., Vincent, F., Faure, S., Messerli, F.H., Wang, J.G., Achard, J.M., Fournier, A., 2005, The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotection. Curr Pharm Des 11, 3275–3291.PubMedGoogle Scholar
  89. Mahmood, T., Djahanbakhch, O., Burleigh, D.E., Puddefoot, J.R., O’Mahony, O.A., Vinson, G.P., 2002, Effect of angiotensin II on ion transport across human Fallopian tube epithelial cells in vitro. Reproduction 124, 573–579.PubMedGoogle Scholar
  90. Mancina, R., Susini, T., Renzetti, A., Forti, G., Razzoli, E., Serio, M., Maggi, M., 1996, Sex steroid modulation of AT(2) receptors in human myometrium. J clin Endocr Metab 81, 1753–1757.PubMedGoogle Scholar
  91. Marsigliante, S., Resta, L., Muscella, A., Vinson, G.P., Marzullo, A., Storelli, C., 1996, AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma. Cancer Let 110, 19–27.Google Scholar
  92. Martin, M.M., White, C.R., Li, H., Miller, P.J., Elton, T.S., 1995, A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR). Regul Pept 60, 135–147.PubMedGoogle Scholar
  93. McKinley, M.J., Albiston, A.L., Allen, A.M., Mathai, M.L., May, C.N., McAllen, R.M., Oldfield, B.J., Mendelsohn, F.A., Chai, S.Y., 2003, The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35, 901–918.PubMedGoogle Scholar
  94. Meier, C.R., Derby, L.E., Jick, S.S., Jick, H., 2000, Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Int Med 160, 349–353.Google Scholar
  95. Millan, M.A., Carvallo, P., Izumi, S., Zemel, S., Catt, K.J., Aguilera, G., 1989, Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 244, 1340–1342.PubMedGoogle Scholar
  96. Motz, W.H., Scheler, S., Strauer, B.E., 1992, Medical repair of hypertensive left ventricular remodeling. J.Cardiovasc.Pharmacol. 20 Suppl 1, S32–S36.PubMedGoogle Scholar
  97. Mukhopadhyay, A.K., Holstein, K., Szkudlinski, M., Brunswig-Spickenheier, B., Leidenberger, F.A., 1991, The relationship between prorenin levels in follicular fluid and follicular atresia in bovine ovaries. Endocrinology 129, 2367–2375.PubMedGoogle Scholar
  98. Mulrow, P.J., 1998, Renin-angiotensin system in the adrenal. Horm.Metab.Res. 30, 346–349.PubMedGoogle Scholar
  99. Mulrow, P.J., 1999, Angiotensin II and aldosterone regulation. Regul Pept 80, 27–32.PubMedGoogle Scholar
  100. Muscella, A., Greco, S., Elia, M.G., Storelli, C., Marsigliante, S., 2002, Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J.Endocrinol. 173, 315–323.PubMedGoogle Scholar
  101. Muscella, A., Greco, S., Elia, M.G., Storelli, C., Marsigliante, S., 2003, PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells. J. Cell. Physiol. 197, 61–68.PubMedGoogle Scholar
  102. Muscella, A., Storelli, C., Marsigliante, S., 2005, Atypical PKC-zeta and PKC-iota mediate opposing effects on MCF-7 Na+/K+ ATPase activity. J. Cell. Physiol. 205, 278–285.PubMedGoogle Scholar
  103. Natarajan, R., Gonzales, N., Hornsby, P.J., Nadler, J., 1992, Mechanism of angiotensin II-induced proliferation in bovine adrenocortical cells. Endocrinology. 131, 1174–1180.PubMedGoogle Scholar
  104. Nicolini, A., Carpi, A., Tarro, G., 2006, Biomolecular markers of breast cancer. Front Biosci 11, 1818–1843.PubMedGoogle Scholar
  105. Nielsen, A.H., Hagemann, A., Poulson, K., 1995, The tissue renin-angiotensin system in the female reproductive tissues. In Tissue renin-angiotensin systems, pp. 253–268, Edited by A.K. Mukhopadhyay and M.K. Raizada, Plenum, New York & London.Google Scholar
  106. Noguchi, S., Miyauchi, K., Nishizawa, Y., Sasaki, Y., Imaoka, S., Iwanaga, T., Koyama, H., Terasawa, T., 1988, Augmentation of anticancer effect with angiotensin II in intraarterial infusion chemotherapy for breast carcinoma. Cancer. 62, 467–473.PubMedGoogle Scholar
  107. Norris, B., Gonzalez, C., Concha, J., Palacios, S., Contreras, G., 1991, Stimulatory Effect of Angiotensin-Ii on Electrolyte Transport in Canine Tracheal Epithelium. Genl Pharmacol 22, 527–531.Google Scholar
  108. Okura, T., Kitami, Y., Wakamiya, R., Marumoto, K., Iwata, T., Hiwada, K., 1992, Renal and extra-renal renin gene expression in spontaneously hypertensive rats. Blood.Press.Suppl. 3, 6–11.PubMedGoogle Scholar
  109. Olivares-Reyes, J.A., Shah, B.H., Hernandez-Aranda, J., Garcia-Caballero, A., Farshori, M.P., Garcia-Sainz, J.A., Catt, K.J., 2005, Agonist-induced interactions between angiotensin AT(1) and epidermal growth factor receptors. Mol Pharm 68, 356–364.Google Scholar
  110. Pal, S.K., Pegram, M., 2005, Epidermal growth factor receptor and signal transduction: potential targets for anti-cancer therapy. Anti-Cancer Drugs 16, 483–494.PubMedGoogle Scholar
  111. Peach, M.T., 1977, Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev 57, 313–370.PubMedGoogle Scholar
  112. Petrovic, I., Petrovic, D., Vukovic, N., Zivanovic, B., Dragicevic, J., Vasiljevic, Z., Babic, R., 2005, Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients. J Int Med Res 33 Suppl 1, 39A–49A.PubMedGoogle Scholar
  113. Phillips, M.I., Speakman, E.A., Kimura, B., 1993, Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul.Pept. 43, 1–20.PubMedGoogle Scholar
  114. Pollard, J.W., 2001, Tumour-stromal interactions - Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res 3, 230–237.PubMedGoogle Scholar
  115. Porteri, E., Rodella, L., Rizzoni, D., Rezzani, R., Paiardi, S., Sleiman, I., De Ciuceis, C., Boari, G.E., Castellano, M., Bianchi, R., Agabiti-Rosei, E., 2005, Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats. Blood Press 14, 184–192.PubMedGoogle Scholar
  116. Pucell, A.G., Bumpus, F.M., Husain, A., 1987, Rat ovarian angiotensin-II receptors - characterization and coupling to estrogen secretion. J.biol.Chem. 262, 7076–7080.PubMedGoogle Scholar
  117. Puddefoot, J.R., Udeozo, U.K.I., Barker, S., Vinson, G.P., 2006, The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion. Endocrine related cancer 13, 895–903.PubMedGoogle Scholar
  118. Quan, A., Baum, M., 1996, Endogenous production of angiotensin-II modulates rat proximal tubule transport. J.Clin.Invest. 97, 2878–2882.PubMedGoogle Scholar
  119. Reddy, M.K., Baskaran, K., Molteni, A., 1995, Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc Soc exp Biol Med 210, 221–226.PubMedGoogle Scholar
  120. Reinhardt, D., Sigusch, H.H., Hensse, J., Tyagi, S.C., Korfer, R., Figulla, H.R., 2002, Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart 88, 525–530.PubMedGoogle Scholar
  121. Rivera, E., Arrieta, O., Guevara, P., Duarte-Rojo, A., Sotelo, J., 2001, AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. Br. J. Cancer 85, 1396–1399.PubMedGoogle Scholar
  122. Ronquist, G., Rodriguez, L.A., Ruigomez, A., Johansson, S., Wallander, M.A., Frithz, G., Svardsudd, K., 2004, Association between captopril, other antihypertensive drugs and risk of prostate cancer. Prostate 58, 50–56.PubMedGoogle Scholar
  123. Ross, J.S., Schenkein, D.P., Pietrusko, R., Rolfe, M., Linette, G.P., Stec, J., Stagliano, N.E., Ginsburg, G.S., Symmans, W.F., Pusztai, L., Hortobagyi, G.N., 2004, Targeted therapies for cancer 2004. Am J clin Pathol 122, 598–609.PubMedGoogle Scholar
  124. Rudolph-Owen, L.A., Matrisian, L.M., 1998, Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia 3, 177–189.PubMedGoogle Scholar
  125. Russo, J., Balogh, G.A., Chen, J.Q., Fernandez, S.V., Fernbaugh, R., Heulings, R., Mailo, D.A., Moral, R., Russo, P.A., Sheriff, F., Vanegas, J.E., Wang, R., Russo, I.H., 2006, The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci 11, 151–172.PubMedGoogle Scholar
  126. Sakata, Y., Yamamoto, K., Mano, T., Nishikawa, N., Yoshida, J., Hori, M., Miwa, T., Masuyama, T., 2004, Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor. Circulation 109, 2143–2149.PubMedGoogle Scholar
  127. Saridogan, E., Djahanbakhch, O., Puddefoot, J.R., Demetroulis, C., Collingwood, K., Mehta, J.G., Vinson, G.P., 1996, Angiotensin II receptors and angiotensin II stimulation of ciliary activity in human fallopian tube. J.Clin.Endocrinol.Metab. 81, 2719–2725.PubMedGoogle Scholar
  128. Schorb, W., Conrad, K.M., Singer, H.A., Dostal, D.E., Baker, K.M., 1995, Angiotensin-II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J mol cell Cardiol 27, 1151–1160.PubMedGoogle Scholar
  129. Sealey, J.E., Itskovitzeldor, J., Rubattu, S., James, G.D., August, P., Thaler, I., Levron, J., Laragh, J.H., 1994, Estradiol-Related and Progesterone-Related Increases in the Renin-Aldosterone System - Studies During Ovarian Stimulation and Early-Pregnancy. J clin Endocr Metab 79, 258–264.PubMedGoogle Scholar
  130. Seltzer, A., Pinto, J.E.B., Viglione, P.N., Correa, F.M.A., Libertun, C., Tsutsumi, K., Steele, M.K., Saavedra, J.M., 1992, Estrogens Regulate Angiotensin-Converting Enzyme and Angiotensin Receptors in Female Rat Anterior-Pituitary. Neuroendocrinology 55, 460–467.PubMedGoogle Scholar
  131. Shah, B.H., Yesilkaya, A., Olivares-Reyes, J.A., Chen, H.D., Hunyady, L., Catt, K.J., 2004, Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: Role of heparin-binding epidermal growth factor. Mol Endocr 18, 2035–2048.Google Scholar
  132. Singer, C.F., Hudelist, G., Galid, A., Kubista, E., 2003, Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment. Drugs of Today 39, 917–926.PubMedGoogle Scholar
  133. Sivaraman, V.S., Wang, H.Y., Nuovo, G.J., Malbon, C.C., 1997, Hyperexpression of mitogen-activated protein kinase in human breast cancer. J.Clin.Invest. 99, 1478–1483.PubMedGoogle Scholar
  134. Small, W., Jr., Molteni, A., Kim, Y.T., Taylor, J.M., Chen, Z., Ward, W.F., 1997, Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture. Breast.Cancer Res.Treat. 44, 217–224.PubMedGoogle Scholar
  135. Smith, R.D., Timmermans, P.B., 1994, Human angiotensin receptor subtypes. Curr Opin Nephrol Hypertens 3, 112–122.PubMedGoogle Scholar
  136. Stroth, U., Unger, T., 1999, The renin-angiotensin system and its receptors. J Cardiovasc Pharmacol 33 Suppl 1, S21–28; discussion S41–23.PubMedGoogle Scholar
  137. Suganuma, T., Ino, K., Shibata, K., Kajiyama, H., Nagasaka, T., Mizutani, S., Kikkawa, F., 2005, Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin. Cancer Res. 11, 2686–2694.PubMedGoogle Scholar
  138. Sun, S.Z., Wang, Y., Li, Q., Tian, Y.J., Liu, M.H., Yu, Y.H., 2006, Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. Chin Med J (Engl) 119, 814–821.Google Scholar
  139. Suzuki, J., Iwai, M., Nakagami, H., Wu, L., Chen, R., Sugaya, T., Hamada, M., Hiwada, K., Horiuchi, M., 2002, Role of angiotensin II-regulated apoptosis through distinct AT(1) and AT(2) receptors in neointimal formation. Circulation 106, 847–853.PubMedGoogle Scholar
  140. Tahmasebi, M., Puddefoot, J.R., Inwang, E.R., Goode, A.W., Carpenter, R., Vinson, G.P., 1998, Transcription of the prorenin gene in normal and diseased breast. Eur.J.Cancer 34, 1777–1782.PubMedGoogle Scholar
  141. Tahmasebi, M., Puddefoot, J.R., Inwang, E.R., Vinson, G.P., 1999, The tissue renin-angiotensin system in human pancreas. J. Endocrinol. 161, 317–322.PubMedGoogle Scholar
  142. Tahmasebi, M., Barker, S., Puddefoot, J.R., Vinson, G.P., 2006, Localisation of renin-angiotensin system (RAS) components in breast. Br J Cancer 95, 67–74.PubMedGoogle Scholar
  143. Tucker, H.A., 2000, Hormones, mammary growth, and lactation: a 41-year perspective. J Dairy Sci 83, 874–884.PubMedCrossRefGoogle Scholar
  144. Uemura, H., Ishiguro, H., Nagashima, Y., Sasaki, T., Nakaigawa, N., Hasumi, H., Kato, S., Kubota, Y., 2005a, Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Mol cancer Therapeut 4, 1699–1709.Google Scholar
  145. Uemura, H., Nakaigawa, N., Ishiguro, H., Kubota, Y., 2005b, Antiproliferative efficacy of angiotensin II receptor blockers in prostate cancer. Curr. Cancer Drug Targets 5, 307–323.Google Scholar
  146. Ushio-Fukai, M., Alexander, R.W., Akers, M., Yin, Q.Q., Fujio, Y., Walsh, K., Griendling, K.K., 1999, Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J.biol.Chem. 274, 22699–22704.PubMedGoogle Scholar
  147. Vila-Porcile, E., Corvol, P., 1998, Angiotensinogen, prorenin, and renin are Co-localized in the secretory granules of all glandular cells of the rat anterior pituitary: an immunoultrastructural study. J Histochem Cytochem 46, 301–311.PubMedGoogle Scholar
  148. Villadsen, R., 2005, In search of a stem cell hierarchy in the human breast and its relevance to breast cancer evolution. Apmis 113, 903–921.PubMedGoogle Scholar
  149. Vinson, G.P., Saridogan, E., Puddefoot, J.R., Djahanbakhch, O., 1997, Tissue renin-angiotensin systems and reproduction. Hum Reprod 12, 651–662.PubMedGoogle Scholar
  150. Vinson, G.P., Ho, M.M., 1998, The adrenal renin/angiotensin system in the rat. Hormone Metab Res 30, 355–359.Google Scholar
  151. Volpert, O.V., Ward, W.F., Lingen, M.W., Chesler, L., Solt, D.B., Johnson, M.D., Molteni, A., Polverini, P.J., Bouck, N.P., 1996, Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J clin Invest 98, 671–679.PubMedCrossRefGoogle Scholar
  152. Wang, T., Giebisch, G., 1996, Effects of angiotensin II on electrolyte transport in the early and late distal tubule in rat kidney. Am.J.Physiol. 271, F143–F149.PubMedGoogle Scholar
  153. Weber, K.T., Brilla, C.G., Janicki, J.S., 1991, Signals for the remodeling of the cardiac interstitium in systemic hypertension. J.Cardiovasc.Pharmacol. 17 Suppl 2, S14–S19.PubMedGoogle Scholar
  154. Weidekamm, C., Hauser, P., Hansmann, C., Schwarz, C., Klingler, H., Mayer, G., Oberbauer, R., 2002, Effects of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells. Wien. Klin. Wochen. 114, 725–729.Google Scholar
  155. Wiseman, B.S., Werb, Z., 2002, Stromal effects on mammary gland development and breast cancer. Science 296, 1046–1049.PubMedGoogle Scholar
  156. Wysolmerski J., and van Houten, N.J. (2002) http://www.endotext.org/pregnancy/pregnancy5/pregnancy5.htmGoogle Scholar
  157. Wolf, G., Neilson, E.G., 1993, Angiotensin II as a renal growth factor. J Am Soc Nephrol 3, 1531–1540.PubMedGoogle Scholar
  158. Wong, P.Y.D., Fu, W.O., Huang, S.J., Law, W.K., 1990, Effect of angiotensins on electrogenic anion transport in monolayer- cultures of rat epididymis. J. Endocrinol. 125, 449–456.PubMedCrossRefGoogle Scholar
  159. Yamada, T., Horiuchi, M., Dzau, V.J., 1996, Angiotensin-II type-2 receptor mediates programmed cell-death. Proc. Natl. Acad. Sci. U. S. A. 93, 156–160.PubMedGoogle Scholar
  160. Yamada, T., Akishita, M., Pollman, M.J., Gibbons, G.H., Dzau, V.J., Horiuchi, M., 1998, Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: An in vitro gene transfer study. Life Sciences 63, PL289-PL295.Google Scholar
  161. Yamaue, H., Tanimura, H., Terashita, S., Iwahashi, M., Tani, M., Tsunoda, T., Tamai, M., Mori, K., 1990, Clinical evaluation of chemotherapy under angiotensin II-induced hypertension in patients with advanced cancer. Nippon.Geka.Hokan. 59, 302–309.PubMedGoogle Scholar
  162. Yang, X., Zhu, M.J., Sreejayan, N., Ren, J., Du, M., 2005, Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway. Mol Cells 20, 263–270.PubMedGoogle Scholar
  163. Yasumatsu, R., Nakashima, T., Masuda, M., Ito, A., Kuratomi, Y., Nakagawa, T., Komune, S., 2004, Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol 130, 567–573.PubMedGoogle Scholar
  164. Yoshiji, H., Kuriyama, S., Noguchi, R., Fukui, H., 2004, Angiotensin-I converting enzyme inhibitors as potential anti- angiogenic agents for cancer therapy. Curr. Cancer Drug Targets 4, 555–567.PubMedGoogle Scholar
  165. Zhang, Z., Li, M., Rayburn, E.R., Hill, D.L., Zhang, R.W., Wang, H., 2005, Oncogenes as novel targets for cancer therapy - (Part I) - Growth factors and protein tyrosine kinases. Am J Pharmacogenom 5, 173–190.Google Scholar
  166. Zimmerman, B.G., Dunham, E.W., 1997, Tissue renin-angiotensin system: a site of drug action? Ann Rev Pharm Tox 37, 53–69.Google Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Gavin P. Vinson
    • 1
  • Stewart Barker
    • 1
  • John R. Puddefoot
    • 1
  • Massoumeh Tahmasebi
    • 1
  1. 1.School of Biological and Chemical SciencesQueen Mary University of LondonLondon E1 4NSUnited Kingdom

Personalised recommendations